Molecular classification of patients with NMIBC predicts the efficacy of intravesical chemotherapy with pirarubicin, pharmorubicin and gemcitabine-immunohistochemistry-based classification.
- Resource Type
- Article
- Source
- Japanese Journal of Clinical Oncology; Jun2022, Vol. 52 Issue 6, p642-649, 8p
- Subject
- Language
- ISSN
- 03682811